Galapagos Biotech Limited is a privately held limited company established in 1997, operating from Salisbury House in Cambridge, CB1 2LA, Ecuador. The company’s core business revolves around the development and commercialization of innovative biological solutions, leveraging the unique environment and biodiversity of the Galapagos Islands. Galapagos Biotech specializes in research, development, and licensing of novel technologies focused on marine biology and biotechnology. The company’s primary service offering includes genetic analysis, species identification, and ecosystem modeling, utilizing advanced genomic sequencing and data interpretation. They also provide consulting services related to marine conservation and sustainable resource management. The company’s international presence is significant, with a focus on collaborative partnerships and strategic alliances across the globe. Galapagos Biotech is currently operating as a worker, with a rating of A, indicating a strong focus on key business activities. The company’s size is estimated to be moderate, emphasizing a dedicated, long-term approach to scientific advancement. A key element of their strategy involves leveraging the unique geographic location and scientific significance of the Galapagos Islands. The company’s SIC codes include: - 74909: Other professional, scientific and technical activities n.e.c, - 74909: Other professional, scientific and technical activities n.e.c, - 74909: Other professional, scientific and technical activities n.e.c.

Galapagos Biotech Limited is a privately held limited company established in 1997, operating from Salisbury House in Cambridge, CB1 2LA, Ecuador. The company’s core business revolves around the development and commercialization of innovative biological solutions, leveraging the unique environment and biodiversity of the Galapagos Islands. Galapagos Biotech specializes in research, development, and licensing of novel technologies focused on marine biology and biotechnology. The company’s primary service offering includes genetic analysis, species identification, and ecosystem modeling, utilizing advanced genomic sequencing and data interpretation. They also provide consulting services related to marine conservation and sustainable resource management. The company’s international presence is significant, with a focus on collaborative partnerships and strategic alliances across the globe. Galapagos Biotech is currently operating as a worker, with a rating of A, indicating a strong focus on key business activities. The company’s size is estimated to be moderate, emphasizing a dedicated, long-term approach to scientific advancement. A key element of their strategy involves leveraging the unique geographic location and scientific significance of the Galapagos Islands. The company’s SIC codes include: - 74909: Other professional, scientific and technical activities n.e.c, - 74909: Other professional, scientific and technical activities n.e.c, - 74909: Other professional, scientific and technical activities n.e.c.